Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
5.07
0.00 (0.00%)
Sep 3, 2025, 4:00 PM - Market closed
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of $78.41 million as of September 4, 2025. Its market cap has increased by 668.76% in one year.
Market Cap
78.41M
Enterprise Value
51.88M
1-Year Change
668.76%
Ranking
Category
Stock Price
$5.07
Market Cap Chart
Since September 29, 2003, Alterity Therapeutics's market cap has increased from $29.30M to $78.41M, an increase of 167.62%. That is a compound annual growth rate of 4.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 77.10M | 166.78% |
Dec 31, 2024 | 28.90M | 186.14% |
Dec 29, 2023 | 10.10M | -27.86% |
Dec 30, 2022 | 14.00M | -44.00% |
Dec 31, 2021 | 25.00M | 7.76% |
Dec 31, 2020 | 23.20M | 107.14% |
Dec 31, 2019 | 11.20M | -1.75% |
Dec 31, 2018 | 11.40M | -58.99% |
Dec 29, 2017 | 27.80M | 91.72% |
Dec 30, 2016 | 14.50M | -62.53% |
Dec 31, 2015 | 38.70M | -51.75% |
Dec 31, 2014 | 80.20M | -70.03% |
Dec 31, 2013 | 267.60M | 307.93% |
Dec 31, 2012 | 65.60M | 61.98% |
Dec 30, 2011 | 40.50M | 38.23% |
Dec 31, 2010 | 29.30M | 9.33% |
Dec 31, 2009 | 26.80M | -30.03% |
Dec 31, 2008 | 38.30M | -36.80% |
Dec 31, 2007 | 60.60M | 55.38% |
Dec 29, 2006 | 39.00M | 95.98% |
Dec 30, 2005 | 19.90M | -57.75% |
Dec 31, 2004 | 47.10M | 43.60% |
Dec 31, 2003 | 32.80M | 11.95% |
Sep 29, 2003 | 29.30M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 660.01B |
Johnson & Johnson | 428.83B |
AbbVie | 374.37B |
UnitedHealth Group | 279.67B |
Novo Nordisk | 248.91B |
AstraZeneca | 247.16B |
Novartis AG | 244.04B |
Abbott Laboratories | 228.80B |